Molecular strategies to inhibit HIV-1 replication

被引:0
|
作者
Morten Hjuler Nielsen
Finn Skou Pedersen
Jørgen Kjems
机构
[1] University of Aarhus,Department of Molecular Biology
来源
关键词
Long Terminal Repeat; Nuclear Export Signal Domain; Primer Binding Site Region;
D O I
暂无
中图分类号
学科分类号
摘要
The human immunodeficiency virus type 1 (HIV-1) is the primary cause of the acquired immunodeficiency syndrome (AIDS), which is a slow, progressive and degenerative disease of the human immune system. The pathogenesis of HIV-1 is complex and characterized by the interplay of both viral and host factors. An intense global research effort into understanding the individual steps of the viral replication cycle and the dynamics during an infection has inspired researchers in the development of a wide spectrum of antiviral strategies. Practically every stage in the viral life cycle and every viral gene product is a potential target. In addition, several strategies are targeting host proteins that play an essential role in the viral life cycle. This review summarizes the main genetic approaches taken in such antiviral strategies.
引用
收藏
相关论文
共 50 条
  • [1] Molecular strategies to inhibit HIV-1 replication
    Nielsen, MH
    Pedersen, FS
    Kjems, J
    RETROVIROLOGY, 2005, 2 (1)
  • [2] Inhibitors of HIV-1 replication that inhibit HPV integrase
    Robinson, WE
    Reinecke, MG
    AbdelMalek, S
    Jia, Q
    Chow, SA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (13) : 6326 - 6331
  • [3] Human β-defensins inhibit HIV-1 replication in vitro
    Quiñones-Mateu, ME
    Lederman, MM
    Feng, Z
    Chakraborty, B
    Weber, J
    Rangel, HR
    Marotta, ML
    Mirza, M
    Jiang, B
    Kiser, P
    Medvik, K
    Weinberg, A
    ANTIVIRAL THERAPY, 2003, 8 (03) : U37 - U37
  • [4] NEW STRATEGIES FOR CONTROL OF HIV-1 REPLICATION
    MATSUDA, Z
    CARINI, C
    YU, XF
    LEE, TH
    ESSEX, M
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (06): : 670 - 670
  • [5] Substituted bisaryl benzamide derivatives to inhibit HIV-1 replication
    Malik, Neha
    Schiltz, Gary
    Song, Chisu
    D'Aquila, Richard
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [6] GADD45 proteins inhibit HIV-1 replication through specific suppression of HIV-1 transcription
    Liang, Zhibin
    Liu, Ruikang
    Zhang, Hui
    Zhang, Suzhen
    Hu, Xiaomei
    Tan, Juan
    Liang, Chen
    Qiao, Wentao
    VIROLOGY, 2016, 493 : 1 - 11
  • [7] 2′,3′-Dialdehyde of ATP, ADP, and Adenosine Inhibit HIV-1 Reverse Transcriptase and HIV-1 Replication
    Schachter, Julieta
    Chaves Valadao, Ana Luiza
    Aguiar, Renato Santana
    Barreto-de-Souza, Victor
    Rossi, Atila Duque
    Arantes, Pablo Ricardo
    Verli, Hugo
    Quintana, Paula Gabriela
    Heise, Norton
    Tanuri, Amilcar
    Bou-Habib, Dumith Chequer
    Persechini, Pedro Muanis
    CURRENT HIV RESEARCH, 2014, 12 (05) : 347 - 358
  • [8] Use of modified U1 snRNAs to inhibit HIV-1 replication
    Sajic, R.
    Lee, K.
    Asai, K.
    Sakac, D.
    Branch, D. R.
    Upton, C.
    Cochrane, A.
    NUCLEIC ACIDS RESEARCH, 2007, 35 (01) : 247 - 255
  • [9] ANTITUBULIN DRUGS INHIBIT HIV-1 REPLICATION BY BLOCKING TYROSINE PHOSPHORYLASES
    NGUYEN, QV
    KING, RL
    PEDIATRIC RESEARCH, 1994, 35 (04) : A189 - A189
  • [10] Human epithelial β-defensins 2 and 3 inhibit HIV-1 replication
    Quiñones-Mateu, ME
    Lederman, MM
    Feng, ZM
    Chakraborty, B
    Weber, J
    Rangel, HR
    Marotta, ML
    Mirza, M
    Jiang, B
    Kiser, P
    Medvik, K
    Sieg, SF
    Weinberg, A
    AIDS, 2003, 17 (16) : F39 - F48